|
1
|
Moradi R and Atik OS: Are orthopedic
surgeons more aware of medical treatment of osteoporotic fractures
in the last decade? Eklem Hastalik Cerrahisi. 25:80–84. 2014.(In
Turkish). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng L, Kelly CJ and Colgan SP:
Physiologic hypoxia and oxygen homeostasis in the healthy
intestine. A review in the theme: Cellular responses to hypoxia. Am
J Physiol Cell Physiol. 309:C350–C360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iranon NN and Miller DL: Interactions
between oxygen homeostasis, food availability, and hydrogen sulfide
signaling. Front Genet. 3:2572012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Atkinson PJ, Cooper TG, Anseth S, Walter
NE, Kargus R and Haut RC: Association of knee bone bruise frequency
with time postinjury and type of soft tissue injury. Orthopedics.
31:4402008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murata K, Ito H, Yoshitomi H, Yamamoto K,
Fukuda A, Yoshikawa J, Furu M, Ishikawa M, Shibuya H and Matsuda S:
Inhibition of miR-92a enhances fracture healing via promoting
angiogenesis in a model of stabilized fracture in young mice. J
Bone Miner Res. 29:316–326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fauzi A, Kamal AF, Kurniawan A and Kodrat
E: Role of sildenafil in acceleration of delayed union fracture
healing on Sprague-Dawley rats model. Br J Med Med Res. 8:419–428.
2015. View Article : Google Scholar
|
|
7
|
Fang TD, Salim A, Xia W, Nacamuli RP,
Guccione S, Song HM, Carano RA, Filvaroff EH, Bednarski MD, Giaccia
AJ and Longaker MT: Angiogenesis is required for successful bone
induction during distraction osteogenesis. J Bone Miner Res.
20:1114–1124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Molica S, Vitelli G, Levato D, Gandolfo GM
and Liso V: Increased serum levels of vascular endothelial growth
factor predict risk of progression in early B-cell chronic
lymphocytic leukaemia. Br J Haematol. 107:605–610. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benita Y, Kikuchi H, Smith AD, Zhang MQ,
Chung DC and Xavier RJ: An integrative genomics approach identifies
Hypoxia inducible factor-1 (HIF-1)-target genes that form the core
response to hypoxia. Nucleic Acids Res. 37:4587–4602. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen D, Tian W, Li Y, Tang W and Zhang C:
Osteoblast-specific transcription factor Osterix (Osx) and HIF-1α
cooperatively regulate gene expression of vascular endothelial
growth factor (VEGF). Biochem Biophys Res Commun. 424:176–181.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lechler P, Klein SM, Prantl L, Englert C,
Renkawitz T and Grifka J: Hypoxic downregulation of cellular
proliferation and loss of phenotype stability in human osteoblasts
is mediated by HIF-1α. Clin Hemorheol Microcirc. 49:279–286.
2011.PubMed/NCBI
|
|
12
|
Lin L, Shen Q, Leng H, Duan X, Fu X and Yu
C: Synergistic inhibition of endochondral bone formation by
silencing Hif1α and Runx2 in trauma-induced heterotopic
ossification. Mol Ther. 19:1426–1432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim HS, Nam JS, Le SS, Kim LS, Ryu BY,
Kang HJ, Choi BS, Ganbold B and Ko YC: Abstract 564: Foxo3a
regulates cell cycle arrest through the regulation of p53, p21 and
GADD45 signaling activity in Quercetin-treated MDA-MB-231 breast
cancer cells. Cancer Res. 73:5642013. View Article : Google Scholar
|
|
14
|
Lu H and Huang H: FOXO1: A potential
target for human diseases. Curr Drug Targets. 12:1235–1244. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown J, Wang H, Suttles J, Graves DT and
Martin M: Mammalian target of rapamycin complex 2 (mTORC2)
negatively regulates toll-like receptor 4-mediated inflammatory
response via FoxO1. J Biol Chem. 286:44295–44305. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim KM, Park SJ, Jung SH, Kim EJ, Jogeswar
G, Ajita J, Rhee Y, Kim CH and Lim SK: miR-182 is a negative
regulator of osteoblast proliferation, differentiation, and
skeletogenesis through targeting FoxO1. J Bone Miner Res.
27:1669–1679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang S, Xu H, Yu S, Cao H, Fan J, Ge C,
Fransceschi RT, Dong HH and Xiao G: Foxo1 mediates insulin-like
growth factor 1 (IGF1)/insulin regulation of osteocalcin expression
by antagonizing Runx2 in osteoblasts. J Biol Chem. 286:19149–19158.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teixeira CC, Liu Y, Thant LM, Pang J,
Palmer G and Alikhani M: Foxo1, a novel regulator of osteoblast
differentiation and skeletogenesis. J Biol Chem. 285:31055–31065.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kubat O, Šmigovec I, Đapić T and Antičević
D: Cystic-like lesions of proximal femur associated with fractures
in children and adolescents-diagnostic and therapeutic dilemma. J.
2012.
|
|
20
|
Madadi F, Shamsian BS, Alavi S, Madadi F,
Eajazi A and Aslani A: Avascular necrosis of the femoral head in
children with acute lymphoblastic leukemia: A 4- to 9-year
follow-up study. Orthopedics. 34:e593–e597. 2011.PubMed/NCBI
|
|
21
|
Canale ST: Fracture of hip in children and
adolescents. Orthop Clin North Am. 21:341–352. 1990.PubMed/NCBI
|
|
22
|
Karatoprak O, Korkmaz MF, Kara AN, Göğüş A
and Işiklar ZU: Early results of autologous mononuclear bone marrow
cell implantation in nontraumatic avascular necrosis of the femoral
head. Acta Orthop Traumatol Turc. 42:178–183. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siggelkow H, Rebenstorff K, Kurre W,
Niedhart C, Engel I, Schulz H, Atkinson MJ and Hüfner M:
Development of the osteoblast phenotype in primary human
osteoblasts in culture: Comparison with rat calvarial cells in
osteoblast differentiation. J Cell Biochem. 75:22–35. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bel Aiba RS, Dimova EY, Görlach A and
Kietzmann T: The role of hypoxia inducible factor-1 in cell
metabolism-a possible target in cancer therapy. Expert Opin Ther
Targets. 10:583–599. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sudarshan S, Sourbier C, Kong HS, Block K,
Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B,
Goode N, et al: Fumarate hydratase deficiency in renal cancer
induces glycolytic addiction and hypoxia-inducible transcription
factor 1alpha stabilization by glucose-dependent generation of
reactive oxygen species. Mol Cell Biol. 29:4080–4090. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu CW, Lin SC, Chen KF, Lai YY and Tsai
SJ: Induction of pyruvate dehydrogenase kinase-3 by
hypoxia-inducible factor-1 promotes metabolic switch and drug
resistance. J Biol Chem. 283:28106–28114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai J and Rabie AB: VEGF: An essential
mediator of both angiogenesis and endochondral ossification. J Dent
Res. 86:937–950. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim CH, Kin JK and Yoon JH: Dendritic
epidermal T cells promote wound healing by production of vascular
endothelial growth factor mediated by HIF-1a signaling. Am J Respir
Crit Care Med. 185:A42722012. View Article : Google Scholar
|
|
30
|
Kiani AA, Kazemi A, Halabian R,
Mohammadipour M, Jahanian-Najafabadi A and Roudkenar MH: HIF-1α
confers resistance to induced stress in bone marrow-derived
mesenchymal stem cells. Arch Med Res. 44:185–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang C, Sun J, Dai Y, Cao P, Zhang L,
Peng S, Zhou Y, Li G, Tang J and Xiang J: HIF-1A and C/EBPs
transcriptionally regulate adipogenic differentiation of bone
marrow-derived MSCs in hypoxia. Stem Cell Res Ther. 6:212015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siqueira MF, Flowers S, Bhattacharya R,
Faibish D, Behl Y, Kotton DN, Gerstenfeld L, Moran E and Graves DT:
FOXO1 modulates osteoblast differentiation. Bone. 48:1043–1051.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moriishi T, Kawai Y, Komori H, Rokutanda
S, Eguchi Y, Tsujimoto Y, Asahina I and Komori T: Bcl2 deficiency
activates FoxO through Akt inactivation and accelerates osteoblast
differentiation. PLoS One. 9:e866292014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Alikhani M, Maclellan CM, Raptis M, Vora
S, Trackman PC and Graves DT: Advanced glycation end products
induce apoptosis in fibroblasts through activation of ROS, MAP
kinases, and the FOXO1 transcription factor. Am J Physiol Cell
Physiol. 292:C850–C856. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen CC, Jeon SM, Bhaskar PT, Nogueira V,
Sundararajan D, Tonic I, Park Y and Hay N: FoxOs inhibit mTORC1 and
activate Akt by inducing the expression of sestrin3 and rictor. Dev
Cell. 18:592–604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hosaka T, Biggs WH III, Tieu D, Boyer AD,
Varki NM, Cavenee WK and Arden KC: Disruption of forkhead
transcription factor (FOXO) family members in mice reveals their
functional diversification. Proc Natl Acad Sci USA. 101:pp.
2975–2980. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen B, Chao L and Chao J: Pivotal role of
JNK-dependent FOXO1 activation in downregulation of kallistatin
expression by oxidative stress. Am J Physiol Heart Circ Physiol.
298:H1048–H1054. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Martinez S, Tanabe KM, Cras-Méneur C,
Abumrad NA, Bernal-Mizrachi E and Permutt M: Inhibition of Foxo1
protects pancreatic islet beta-cells against fatty acid and
endoplasmic reticulum stress-induced apoptosis. Diabetes.
57:846–859. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Alikhani M, Alikhani Z and Graves DT:
FOXO1 functions as a master switch that regulates gene expression
necessary for tumor necrosis factor-induced fibroblast apoptosis. J
Biol Chem. 280:12096–12102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kwon TG, Zhao X, Yang Q, Li Y, Ge C, Zhao
G and Franceschi RT: Physical and functional interactions between
Runx2 and HIF-1α induce vascular endothelial growth factor gene
expression. J Cell Biochem. 112:3582–3593. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirata M, Kugimiya F, Fukai A, Saito T,
Yano F, Ikeda T, Mabuchi A, Sapkota BR, Akune T, Nishida N, et al:
C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the
target and HIF-2α as the inducer in chondrocytes. Hum Mol Genet.
21:1111–1123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee SH, Che X, Jeong JH, Choi JY, Lee YJ,
Lee YH, Bae SC and Lee YM: Runx2 protein stabilizes
hypoxia-inducible factor-1α through competition with von
Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth
plate hypertrophic chondrocytes. J Biol Chem. 287:14760–14771.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sierra J, Villagra A, Paredes R, Cruzat F,
Gutierrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, Van
Wijnen AJ, et al: Regulation of the bone-specific osteocalcin gene
by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not
p300 intrinsic histone acetyltransferase activity. Mol Cell Biol.
23:3339–3351. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiao G, Jiang D, Ge C, Zhao Z, Lai Y,
Boules H, Phimphilai M, Yang X, Karsenty G and Franceschi RT:
Cooperative interactions between activating transcription factor 4
and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene
expression. J Biol Chem. 280:30689–30696. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Komori T: Regulation of osteoblast
differentiation by Runx2. Adv Exp Med Biol. 658:43–49. 2010.
View Article : Google Scholar : PubMed/NCBI
|
